Gen Suzuki, Naofumi Hayabuchi, Seiji Kurata, Masatora Aoki, Tadashi Nakashima
{"title":"[Early-stage carcinoma of the external auditory canal treated by intracavitary irradiation with HDR 192Ir-RALS: a case report].","authors":"Gen Suzuki, Naofumi Hayabuchi, Seiji Kurata, Masatora Aoki, Tadashi Nakashima","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>We report a case of early-stage carcinoma of the external auditory canal treated by intracavitary irradiation with high-dose-rate (HDR) 192Ir-RALS after 40 Gy by external irradiation. We made an applicator that was inserted into the external auditory canal for the intracavitary irradiation, using a 9 Fr silicone catheter and resin. The total intracavitary radiation dosages were 20 Gy/8 Fr/4 weeks. No severe side effects were noted, and the tumor disappeared. RALS may be indicated for early carcinoma of the external auditory canal for its efficacy and lack of side effects.</p>","PeriodicalId":19251,"journal":{"name":"Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica","volume":"64 7","pages":"398-400"},"PeriodicalIF":0.0000,"publicationDate":"2004-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
We report a case of early-stage carcinoma of the external auditory canal treated by intracavitary irradiation with high-dose-rate (HDR) 192Ir-RALS after 40 Gy by external irradiation. We made an applicator that was inserted into the external auditory canal for the intracavitary irradiation, using a 9 Fr silicone catheter and resin. The total intracavitary radiation dosages were 20 Gy/8 Fr/4 weeks. No severe side effects were noted, and the tumor disappeared. RALS may be indicated for early carcinoma of the external auditory canal for its efficacy and lack of side effects.